Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Materials Chemistry and Physics|August 28, 2019
Novel magnetic core-shell nanoparticles for the removal of polychlorinated biphenyls from contaminated water sourcesAngela M Gutierrez, Rohit Bhandari, Jiaying Weng, et al.Journal of Applied Polymer Science|July 26, 2021
Synthesis of magnetic nanocomposite microparticles for binding of chlorinated organics in contaminated water sourcesAngela M Gutierrez, Rohit Bhandari, Jiaying Weng, et al.BMC Neurology|May 21, 2020
Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraineVirginia L Stauffer, Shufang Wang, Jo Bonner, et al.Materials Today. Communications|October 10, 2017
Synthesis and characterization of thermally responsive N-isopropylacrylamide hydrogels copolymerized with novel hydrophobic polyphenolic crosslinkersShuo Tang, Rohit Bhandari, Sean P Delaney, et al.Headache|January 22, 2021
Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraineRebecca M Speck, Ren Yu, Janet H Ford, et al.ACS Omega|January 6, 2018
Synthesis and Characterization of Thermoresponsive Hydrogels Based on N-Isopropylacrylamide Crosslinked with 4,4'-Dihydroxybiphenyl DiacrylateShuo Tang, Martha Floy, Rohit Bhandari, et al.Langmuir : the ACS Journal of Surfaces and Colloids|June 4, 2015
Electrochemical Activity of Dendrimer-Stabilized Tin Nanoparticles for Lithium Alloying ReactionsRohit Bhandari, Rachel M Anderson, Shannon Stauffer, et al.Journal of Medical Economics|May 5, 2022
Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trialsJoshua Tobin, Janet H Ford, Antje Tockhorn-Heidenreich, et al.Pageof 2